Skip to main content

Table 1 Patient characteristics at baseline.

From: Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy

Subject

Age (years)

Sex

Years since Dx

Weight (kg)

BMI (kg/m2)

BMI SDS

1

15.8

F

4.4

95.5

34.7

2.03

2

18.3

F

4.7

135.3

45.4

2.41

3

16.2

F

6.3

92.4

35.4

2.00

4*

11.4

F

5.7

66.0

32.8

2.32

5

16.1

M

8.0

121.6

37.7

2.54

6*

15.9

F

8.7

156.5

65.1

2.96

7

14.7

M

7.3

75.7

28.3

1.8

8

17.1

M

8.1

112.0

34.0

2.14

9

9.2

F

2.8

56.8

29.6

2.48

  1. Dx: diagnosis of craniopharyngioma; BMI: body mass index; SDS: standard deviation score. *Denotes subjects who were withdrawn from the study due to vomiting with mild elevation of hepatic enzymes (subject 4) and peripheral edema (subject 6).